News

Early-phase trials team

Clinical Trial of Anti-VISTA Cancer Antibody Therapy Opens for Patient Enrollment

Dartmouth-Hitchcock Norris Cotton Cancer Center leads a new multi-center Phase I in-human clinical trial of anti-VISTA, a therapeutic antibody designed to target a molecule that keeps the immune system quiet against cancer.

View story

Jason Faris, MD

New Grant Will Improve Rural Patient Access to Cancer Clinical Trials

A newly awarded $820,000 grant from The National Cancer Institute (NCI) will allow a team of investigators to increase clinical trial awareness and participation for rural patients.

View story

Idylla device

Rapid Genomic Profiling of Colon Cancers can Improve Therapy Selection for Patients

Multicenter study led by NCCC shows vastly improved turnaround time to get results from the lab to the oncologist using the newest technology in the cancer testing space.

View story